Skip to search formSkip to main contentSkip to account menu

Arformoterol Tartrate

The tartrate salt of arformoterol, the (R,R)-enantiomer of formoterol and a long-acting beta-2 adrenergic agonist with bronchodilator activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract Objective: This retrospective cohort study compared exacerbations, health services utilization, and costs among chronic… 
2014
2014
BACKGROUND: Arformoterol tartrate (arformoterol, 15 μg bid) is a nebulized long-acting β2-agonist approved for maintenance… 
2013
2013
Background Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden… 
Review
2013
Review
2013
Chronic obstructive pulmonary disease (COPD) is a serious global health burden. Comprehensive management of COPD includes both… 
Review
2010
Review
2010
Some basic scientific data suggest that (S)-enantiomers of β2-agonists have different and sometimes opposing effects to (R… 
2007
2007
ABSTRACT Objective: Arformoterol tartrate inhalation solution (15 μg/2 mL) is approved for the twice-daily, long-term maintenance… 
2006
2006
β 2 -Adrenoceptor agonists are widely used as adjuncts to corticosteroids for the treatment of chronic obstructive pulmonary… 
Review
2004
Review
2004
  • Drugs in R&D
  • 2004
  • Corpus ID: 6119930
Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the beta(2)-adrenoceptor agonist…